Zhaoke Ophthalmology Limited announced that, with effect from June 1, 2021, Dr. Albert Tsai Jr. ("Dr. Tsai") has been appointed as the Chief Medical Officer of the Company, who will be primarily responsible for leading the Group to advance its assets through the clinical development process as well as supporting the post approval medical affairs for the Group's commercial products (e.g. safety, risk management, thought leader relationships). Dr. Tsai has 20 years of healthcare experience across the spectrum of pharmaceuticals, biotech, medical devices and healthcare consulting, as well as in various country markets including China, US, Japan and Southeast Asia. From 2019 to 2021, he served as the Vice President, Regional Medical Officer of the Asia-Pacific region at PPD Inc.